Stay updated on Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces the previous v3.3.1 label on the page header/footer. This is a minor metadata update and does not affect the study details or navigation.
    Difference
    0.0%
    Check dated 2025-11-28T02:39:53.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Publications notes now clarify that the list is auto-populated from PubMed, and reflect Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-20T22:39:12.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Notice regarding government funding status and NIH operation updates has been removed from the page. This change does not alter the study details, eligibility, outcomes, or how users interact with the page.
    Difference
    0.2%
    Check dated 2025-11-13T16:59:47.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    No significant changes detected; the page content, study details, eligibility criteria, and locations remain the same.
    Difference
    0.3%
    Check dated 2025-10-30T11:20:10.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Updated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.
    Difference
    0.0%
    Check dated 2025-10-01T04:42:50.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.0%
    Check dated 2025-09-30T03:44:47.000Z thumbnail image

Stay in the know with updates to Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.